Return to Vaccination News Home Page __» Right-click to "open in new window"
Subscribe to the Vaccination NewsLetter
View past & current Scandals (columns by Sandy Mintz)
Search This Site using keywords
http://pediatrics.aappublications.org/cgi/content/abstract/112/1/193
|
|
||||||||
Pertussis Influenza Hepatitis B Haemophilus influenzae Infections Diphtheria Tetanus (Lockjaw) |
PEDIATRICS Vol. 112 No. 1 July 2003, pp. 193-198
CLINICAL REPORT |
ABSTRACT
Preterm (PT) infants are at increased risk of experiencing complications of vaccine-preventable diseases but are less likely to receive immunizations on time. Medically stable PT and low birth weight (LBW) infants should receive full doses of diphtheria, tetanus, acellular pertussis, Haemophilus influenzae type b, hepatitis B, poliovirus, and pneumococcal conjugate vaccines at a chronologic age consistent with the schedule recommended for full-term infants. Infants with birth weight less than 2000 g may require modification of the timing of hepatitis B immunoprophylaxis depending on maternal hepatitis B surface antigen status. All PT and LBW infants benefit from receiving influenza vaccine beginning at 6 months of age before the beginning of and during the influenza season. All vaccines routinely recommended during infancy are safe for use in PT and LBW infants. The occurrence of mild vaccine-attributable adverse events are similar in both full-term and PT vaccine recipients. Although the immunogenicity of some childhood vaccines may be decreased in the smallest PT infants, antibody concentrations achieved usually are protective.
Abbreviations: PT, preterm • LBW, low birth weight • VLBW, very low birth weight • ELBW, extremely low birth weight • HBV, hepatitis B virus • DTaP, diphtheria and tetanus toxoids and acellular pertussis • IPV, inactivated poliovirus • Hib, Haemophilus influenzae type b • FT, full-term • PCV7, heptavalent pneumococcal conjugate vaccine • AAP, American Academy of Pediatrics • HBsAg, hepatitis B surface antigen • anti-HBs, antibody to hepatitis B surface antigen • DTwP, diphtheria and tetanus toxoids and whole-cell pertussis • OPV, oral poliovirus • MCV, meningococcal C conjugate vaccine • CLD, chronic lung disease • HBIG, Hepatitis B Immune Globulin
Return to Vaccination News Home Page __» Right-click to "open in new window"
DISCLAIMER: All information, data, and material contained, presented, or provided here is for general information purposes only and is not to be construed as reflecting the knowledge or opinions of the publisher, and is not to be construed or intended as providing medical or legal advice. The decision whether or not to vaccinate is an important and complex issue and should be made by you, and you alone, in consultation with your health care provider.